Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Portage Biotech Inc. PRTG
$3.24
+$0.08 (2.53%)
На 18:04, 12 мая 2023
+501.85%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
53864142.00000000
-
week52high
11.99
-
week52low
2.34
-
Revenue
0
-
P/E TTM
-3
-
Beta
109.23010000
-
EPS
-1.27000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 июл 2023 г. в 12:30
Описание компании
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; TT-10, an adenosine receptor type 2A (A2A) inhibitor to treat A2A expressing solid tumors; TT-4, an adenosine receptor type 2B (A2B) inhibitor to treat solid tumors; TT-53, an A2A/A2B inhibitor to treat solid tumors; TT-3, an A2B inhibitor to treat colorectal and gastrointestinal cancers; and NT230-6 that is in Phase I/II clinical trials for the treatment of tumors. It also provides Nanolipogel (NLG) co-formulation platform for delivery of DNA aptamers and certain aptamer-small molecule-based combination products; and STING agonist platform, a proprietary immune priming and boosting technology, offers various ways to target immune stimulation towards the cancer, as well as to co-deliver various signals in a single product. The company is based in Tortola, British Virgin Islands.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 07 мар 2022 г. | |
| Oppenheimer | Outperform | 21 сент 2021 г. | |
| B. Riley Securities | Buy | 02 сент 2021 г. | |
| Cantor Fitzgerald | Overweight | 19 авг 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 20 сент 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 01 дек 2022 г. |
| Oppenheimer | Outperform | Outperform | 30 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
New Strong Buy Stocks for January 26th
Zacks Investment Research
26 янв 2023 г. в 09:02
FYBR, SPPJY, KMTUY, PRTG and ASML have been added to the Zacks Rank #1 (Strong Buy) List on January 26, 2023.
New Strong Buy Stocks for January 20th
Zacks Investment Research
20 янв 2023 г. в 07:32
NBSE, PRTG, RELL, HOWL and PATH have been added to the Zacks Rank #1 (Strong Buy) List on January 20, 2022.
New Strong Buy Stocks for November 1st
Zacks Investment Research
01 ноя 2022 г. в 10:32
FFNW, PTEN, PRTG, NTNX and GAMB have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2022.
Does Portage Biotech Inc. (PRTG) Have the Potential to Rally 206% as Wall Street Analysts Expect?
Zacks Investment Research
01 авг 2022 г. в 11:37
The mean of analysts' price targets for Portage Biotech Inc. (PRTG) points to a 206.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Portage Biotech Shares Gain On Buying Outstanding Minority Interest In iNKT Platform
Benzinga
20 июл 2022 г. в 16:07
Portage Biotech Inc (NASDAQ: PRTG) acquired the remaining 22% stake in its invariant natural killer T cell (iNKT agonist) platform and now wholly owns the worldwide rights to its small molecule iNKT agonists, including lead programs PORT-2 and PORT-3. The platform was acquired.